BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 27400918)

  • 21. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity.
    Skálová A; Vanecek T; Sima R; Laco J; Weinreb I; Perez-Ordonez B; Starek I; Geierova M; Simpson RH; Passador-Santos F; Ryska A; Leivo I; Kinkor Z; Michal M
    Am J Surg Pathol; 2010 May; 34(5):599-608. PubMed ID: 20410810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary Mammary Analog Secretory Carcinoma (MASC) of the Vulva With ETV6-NTRK3 Fusion: A Case Report.
    Nguyen JK; Bridge JA; Joshi C; McKenney JK
    Int J Gynecol Pathol; 2019 May; 38(3):283-287. PubMed ID: 29672325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Secretory Carcinoma with ETV6-NTRK3 Gene Fusion and Lymph Node Metastasis in Maxillary Gingiva: A Case Report with Pathological and Molecular Correlative Studies.
    Fujita J; Krishnan B; Green LK; Sandulache VC; Lai S
    Ann Clin Lab Sci; 2023 Sep; 53(5):800-805. PubMed ID: 37945013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morphology in conjunction with immunohistochemistry is sufficient for the diagnosis of mammary analogue secretory carcinoma.
    Shah AA; Wenig BM; LeGallo RD; Mills SE; Stelow EB
    Head Neck Pathol; 2015 Mar; 9(1):85-95. PubMed ID: 25078757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mammary analog secretory carcinoma, low-grade salivary duct carcinoma, and mimickers: a comparative study.
    Stevens TM; Kovalovsky AO; Velosa C; Shi Q; Dai Q; Owen RP; Bell WC; Wei S; Althof PA; Sanmann JN; Sweeny L; Carroll WR; Siegal GP; Bullock MJ; Brandwein-Gensler M
    Mod Pathol; 2015 Aug; 28(8):1084-100. PubMed ID: 26089091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ETV6 rearrangement in a case of mammary analogue secretory carcinoma of the skin.
    Chang MD; Arthur AK; García JJ; Sukov WR; Shon W
    J Cutan Pathol; 2016 Nov; 43(11):1045-1049. PubMed ID: 27506949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macrocystic (Mammary Analogue) Secretory Carcinoma: An Unusual Variant and a Pitfall in the Differential Diagnosis of Cystic Lesions in the Head and Neck.
    Hernandez-Prera JC; Holmes BJ; Valentino A; Harshan M; Bacchi CE; Petersson F; Liu KK; Najfeld V; Wenig BM
    Am J Surg Pathol; 2019 Nov; 43(11):1483-1492. PubMed ID: 31464708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mammary analogue secretory carcinoma of salivary gland origin: an update and expanded morphologic and immunohistochemical spectrum of recently described entity.
    Skalova A
    Head Neck Pathol; 2013 Jul; 7 Suppl 1(Suppl 1):S30-6. PubMed ID: 23821207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomic profiling of breast secretory carcinomas reveals distinct genetics from other breast cancers and similarity to mammary analog secretory carcinomas.
    Krings G; Joseph NM; Bean GR; Solomon D; Onodera C; Talevich E; Yeh I; Grenert JP; Hosfield E; Crawford ED; Jordan RC; van Zante A; Zaloudek C; Shin SJ; Chen YY
    Mod Pathol; 2017 Aug; 30(8):1086-1099. PubMed ID: 28548128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mammary Analog Secretory Carcinoma With ETV6 Rearrangement Arising in the Conjunctiva and Eyelid.
    Bao Y; Li J; Zhu Y
    Am J Dermatopathol; 2018 Jul; 40(7):531-535. PubMed ID: 29251639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The screening and electron microscopy observation of mammary analogue secretory carcinoma in Chinese.
    Zhong Y; Liu L; Qi B; Song X; Shen L; Li H
    J Craniomaxillofac Surg; 2018 Jun; 46(6):893-897. PubMed ID: 29752049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathologic and Molecular Characterization of Four Cases of Pediatric Salivary Secretory Carcinoma (SSC), One with ETV6-RET Fusion.
    Salgado CM; Alaggio R; Reyes-Múgica M; Zin A; de Vito R
    Head Neck Pathol; 2021 Sep; 15(3):796-802. PubMed ID: 33459993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expanding the Molecular Spectrum of Secretory Carcinoma of Salivary Glands With a Novel VIM-RET Fusion.
    Skálová A; Banečkova M; Thompson LDR; Ptáková N; Stevens TM; Brcic L; Hyrcza M; Michal M; Simpson RHW; Santana T; Michal M; Vaněček T; Leivo I
    Am J Surg Pathol; 2020 Oct; 44(10):1295-1307. PubMed ID: 32675658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of mammaglobin immunohistochemistry as a proxy marker for the ETV6-NTRK3 translocation in the diagnosis of salivary mammary analogue secretory carcinoma.
    Bishop JA; Yonescu R; Batista D; Begum S; Eisele DW; Westra WH
    Hum Pathol; 2013 Oct; 44(10):1982-8. PubMed ID: 23773480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined DOG1 and Mammaglobin Immunohistochemistry Is Comparable to ETV6-breakapart Analysis for Differentiating Between Papillary Cystic Variants of Acinic Cell Carcinoma and Mammary Analogue Secretory Carcinoma.
    Said-Al-Naief N; Carlos R; Vance GH; Miller C; Edwards PC
    Int J Surg Pathol; 2017 Apr; 25(2):127-140. PubMed ID: 27670353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mammary analogue secretory carcinoma: A case report.
    Hedhli F; Ouertani H; Gargouri F; Naija S; Casiraghi O; Valent A; Khatteche B
    Tunis Med; 2020 Feb; 98(2):168-171. PubMed ID: 32395809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC).
    Drilon A; Li G; Dogan S; Gounder M; Shen R; Arcila M; Wang L; Hyman DM; Hechtman J; Wei G; Cam NR; Christiansen J; Luo D; Maneval EC; Bauer T; Patel M; Liu SV; Ou SH; Farago A; Shaw A; Shoemaker RF; Lim J; Hornby Z; Multani P; Ladanyi M; Berger M; Katabi N; Ghossein R; Ho AL
    Ann Oncol; 2016 May; 27(5):920-6. PubMed ID: 26884591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mammary analogue secretory carcinoma of the salivary glands: a diagnostic dilemma.
    Hindocha N; Wilson MH; Pring M; Hughes CW; Thomas SJ
    Br J Oral Maxillofac Surg; 2017 Apr; 55(3):290-292. PubMed ID: 27527989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mammary analogue secretory carcinoma of salivary glands: a clinicopathologic and molecular study including 2 cases harboring ETV6-X fusion.
    Ito Y; Ishibashi K; Masaki A; Fujii K; Fujiyoshi Y; Hattori H; Kawakita D; Matsumoto M; Miyabe S; Shimozato K; Nagao T; Inagaki H
    Am J Surg Pathol; 2015 May; 39(5):602-10. PubMed ID: 25651470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathological features of mammary analogue secretory carcinoma of the salivary gland.
    Shi K; Lv XQ
    Int J Clin Exp Pathol; 2017; 10(7):7460-7465. PubMed ID: 31966589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.